Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution

被引:101
作者
Purohit, Hitesh S. [1 ]
Taylor, Lynne S. [1 ]
机构
[1] Purdue Univ, Coll Pharm, Dept Ind & Phys Pharm, W Lafayette, IN 47907 USA
基金
美国国家卫生研究院; 美国国家科学基金会;
关键词
amorphous-amorphous phase separation; amorphous solid dispersion; dissolution; fluorescence spectroscopy; liquid-liquid phase separation; WATER-SOLUBLE DRUGS; SUPERSATURATED SOLUTIONS; PHARMACEUTICAL SYSTEMS; MEMBRANE-TRANSPORT; NILE RED; SEPARATION; SOLUBILITY; PROBE; POLYVINYLPYRROLIDONE; FLUORESCENCE;
D O I
10.1007/s11095-017-2265-5
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The aim of this research was to study the interplay of solid and solution state phase transformations during the dissolution of ritonavir (RTV) amorphous solid dispersions (ASDs). RTV ASDs with polyvinylpyrrolidone (PVP), polyvinylpyrrolidone vinyl acetate (PVPVA) and hydroxypropyl methylcellulose acetate succinate (HPMCAS) were prepared at 10-50% drug loading by solvent evaporation. The miscibility of RTV ASDs was studied before and after exposure to 97% relative humidity (RH). Non-sink dissolution studies were performed on fresh and moisture-exposed ASDs. RTV and polymer release were monitored using ultraviolet-visible spectroscopy. Techniques including fluorescence spectroscopy, confocal imaging, scanning electron microscopy (SEM), atomic force microscopy (AFM), differential scanning calorimetry (DSC) and nanoparticle tracking analysis (NTA) were utilized to monitor solid and the solution state phase transformations. All RTV-PVP and RTV-PVPVA ASDs underwent moisture-induced amorphous-amorphous phase separation (AAPS) on high RH storage whereas RTV-HPMCAS ASDs remained miscible. Non-sink dissolution of PVP- and PVPVA-based ASDs at low drug loadings led to rapid RTV and polymer release resulting in concentrations in excess of amorphous solubility, liquid-liquid phase separation (LLPS) and amorphous nanodroplet formation. High drug loading PVP- and PVPVA-based ASDs did not exhibit LLPS upon dissolution as a consequence of extensive AAPS in the hydrated ASD matrix. All RTV-HPMCAS ASDs led to LLPS upon dissolution. RTV ASD dissolution is governed by a competition between the dissolution rate and the rate of phase separation in the hydrated ASD matrix. LLPS was observed for ASDs where the drug release was polymer controlled and only ASDs that remained miscible during the initial phase of dissolution led to LLPS. Techniques such as fluorescence spectroscopy, confocal imaging and SEM were useful in understanding the phase behavior of ASDs upon hydration and dissolution and were helpful in elucidating the mechanism of generation of amorphous nanodroplets.
引用
收藏
页码:2842 / 2861
页数:20
相关论文
共 50 条
[31]   Insights into the Dissolution Behavior of Ledipasvir-Copovidone Amorphous Solid Dispersions: Role of Drug Loading and Intermolecular Interactions [J].
Que, Chailu ;
Lou, Xiaochun ;
Zemlyanov, Dmitry Y. ;
Mo, Huaping ;
Indulkar, Anura S. ;
Gao, Yi ;
Zhang, Geoff G. Z. ;
Taylor, Lynne S. .
MOLECULAR PHARMACEUTICS, 2019, 16 (12) :5054-5067
[32]   Dissolution of copovidone-based amorphous solid dispersions: Influence of atomic layer coating, hydration kinetics, and formulation [J].
Benson, Emily G. ;
Moseson, Dana E. ;
Bhalla, Shradha ;
Wang, Fei ;
Wang, Miaojun ;
Zheng, Kai ;
Narwankar, Pravin K. ;
Taylor, Lynne S. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2025, 114 (01) :323-335
[33]   Predicting in vivo performance of fenofibrate amorphous solid dispersions using in vitro non-sink dissolution and dissolution permeation setup [J].
Lentz, Karoline Aagaard ;
Plum, Jakob ;
Steffansen, Bente ;
Arvidsson, Per-Ola ;
Omkvist, Diana H. ojmark ;
Pedersen, Anders Just ;
Sennbro, Carl Johan ;
Pedersen, Gitte Pommergaard ;
Jacobsen, Jette .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2021, 610
[34]   Explaining the Release Mechanism of Ritonavir/PVPVA Amorphous Solid Dispersions [J].
Krummnow, Adrian ;
Danzer, Andreas ;
Voges, Kristin ;
Dohrn, Stefanie ;
Kyeremateng, Samuel O. ;
Degenhardt, Matthias ;
Sadowski, Gabriele .
PHARMACEUTICS, 2022, 14 (09)
[35]   Modelling phase separation in amorphous solid dispersions [J].
Meere, Martin ;
Pontrelli, Giuseppe ;
McGinty, Sean .
ACTA BIOMATERIALIA, 2019, 94 :410-424
[36]   Dissolution and precipitation behavior of ternary solid dispersions of ezetimibe in biorelevant media [J].
Alhayali, Amani ;
Tavellin, Staffan ;
Velaga, Sitaram .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2017, 43 (01) :79-88
[37]   Role of Drug Loading and Microenvironmental pH in Generation of Nanospecies during Dissolution of Eudragit-Based Amorphous Solid Dispersions [J].
Chakraborty, Soumalya ;
Mondal, Utsab ;
Bansal, Arvind K. .
MOLECULAR PHARMACEUTICS, 2025, 22 (07) :3885-3899
[38]   Initial Drug Dissolution from Amorphous Solid Dispersions Controlled by Polymer Dissolution and Drug-Polymer Interaction [J].
Chen, Yuejie ;
Wang, Shujing ;
Wang, Shan ;
Liu, Chengyu ;
Su, Ching ;
Hageman, Michael ;
Hussain, Munir ;
Haskell, Roy ;
Stefanski, Kevin ;
Qian, Feng .
PHARMACEUTICAL RESEARCH, 2016, 33 (10) :2445-2458
[39]   Amorphous Solid Dispersions Containing Residual Crystallinity: Competition Between Dissolution and Matrix Crystallization [J].
Moseson, Dana E. ;
Corum, Isaac D. ;
Lust, Andres ;
Altman, Kevin J. ;
Hiew, Tze Ning ;
Eren, Ayse ;
Nagy, Zoltan K. ;
Taylor, Lynne S. .
AAPS JOURNAL, 2021, 23 (04)
[40]   Comparison of Amorphous Solid Dispersions of Spironolactone Prepared by Spray Drying and Electrospinning: The Influence of the Preparation Method on the Dissolution Properties [J].
Szabo, Edina ;
Zahonyi, Petra ;
Brecska, Daniel ;
Galata, Dorian L. ;
Meszaros, Lilla A. ;
Madarasz, Lajos ;
Csorba, Kristof ;
Vass, Panna ;
Hirsch, Edit ;
Szafraniec-Szczesny, Joanna ;
Csontos, Istvan ;
Farkas, Attila ;
Van denMooter, Guy ;
Nagy, Zsombor K. ;
Marosi, Gyorgy .
MOLECULAR PHARMACEUTICS, 2021, 18 (01) :317-327